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Antimicrobial activityAbstract A POCl3 catalyzed, efficient, one-step and solvent-free synthesis of novel thieno[2,3-d]
pyrimidin-4(3H)-one derivatives from 2-amino-4,5-substitutedthiophene-3-carbonitrile has been
developed under conventional heating and microwave irradiation. The formation of compounds
was confirmed using elemental analysis and spectroscopic techniques like IR, NMR (1H and 13C)
and mass spectroscopy. Furthermore, they were screened in vitro to study their antimicrobial activ-
ity, which shows weak to moderate activity against all tested microorganisms.
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In the current era, antibiotics and synthetic antimicrobial
agents have changed the scenario of the medical field in the
treatment of various bacterial and fungal infections. However,
occurrence of various drug-resistant microbial strains posed a
concrete contest to the medicinal chemists [1]. So, the medici-
nal chemists are working to develop new chemical entities to
conquer drug resistant strains.
Thienopyrimidine, having structural resemblance to purine,
is an important class of therapeutic drugs having a broad rangeof biological activities. Various diversified biological activities
such as antibacterial [2–5], antimicrobial [6–8], antiviral [9],
anti-HIV and anti-HSV [3], anti-avian influenza virus
(H5N1) [10], anti-inflammatory [5,7], analgesic [5,11], antide-
pressant and sedative [11] have been reported for thienopyrim-
idine derivatives.
Various synthetic approaches have been utilized for the
synthesis of thienopyrimidines [12]. Recently, Bakavoli et al.
[4] used molecular iodine as an oxidizing agent for the synthe-
sis of thienopyrimidine via an oxidative heterocyclisation reac-
tion. However, the synthesis of thienopyrimidine from 2-
amino-4,5-substitutedthiophene-3-carbonitrile requires two
steps, we tried to develop a single step and solvent-free method
to generate a series of thieno[2,3-d]pyrimidin-4(3H)-one
derivatives.
In recent times, microwave assisted synthesis of medicinal
compounds has gained appreciation among the synthetic che-
mists due to their improved selectivity, shorter reaction time,
eco-friendliness and superior work-up procedures [13]. Litera-e deriva-
2 D.K. Sureja, K.R. Vadaliature survey also revealed the importance of the microwave
irradiation technique for the synthesis of thienopyrimidine
from 2-amino-4,5-substituted-3-carbethoxythiophene [14,15].
So, herewith we are reporting the efficient synthesis of
thieno[2,3-d] pyrimidin-4(3H)-one derivatives from 2-amino-
4,5-substitutedthiophene-3-carbonitrile by conventional heat-
ing as well as by microwave assisted synthesis using POCl3
as a chlorinating and oxidizing agent.
2. Experimental protocols
2.1. Materials and methods
All the chemicals and solvents used were of LR grade,
obtained from SD fine chemicals and Merck (Mumbai, India).
The progress of reaction was tested on precoated silica gel F254
plates obtained from Merck (Mumbai, India) using the mobile
phase toluene and ethyl acetate in 7:3 ratio. Iodine chamber
and UV lamp (k= 254 nm) were used for visualization of
the spots. Chemline CL726 melting point apparatus was used
for measurement of melting points in an open capillary tube
and are uncorrected. The IR spectra (vmax, cm
1) were
recorded on Shimadzu FT-IR 157 spectrophotometer as KBr
disk. 1H NMR and 13C NMR (d, ppm) spectra were recorded
on Bruker advance III 500 MHz NMR spectrophotometer
operating at 500 MHz and 125 MHz for 1H and 13C respec-
tively in CDCl3/DMSO-d6 using TMS as reference standard.
Mass spectra were recorded on Shimadzu GC-MS-QP2010
mass spectrometer. Elementar Vario EL III CHN analyzer
was used for elemental analysis and results were found within
±0.4% of the calculated value.
2.2. General procedure for preparation of 2-amino-4,5-
substitutedthiophene-3-carbonitrile (1f–g)
4-Methylcyclohexanone or 1,3-cyclohexanedione (0.01 M),
malanonitrile (0.01 M), sulfur (0.01 M) and ethanol (10 mL)
were mixed in a conical flask. The reaction mixture was
warmed up to 40-50 C on a water bath and then diethylamine
(1 mL) was added with constant stirring in such a way that the
temperature does not exceed 50 C. Stirring was continued for
1-2 h till solid crystals gets separated. The reaction mixture was
then cooled and kept in a refrigerator. The fine crystals thus
obtained were filtered, dried and recrystallized from a suitable
solvent to give target compounds in good yields.
2.2.1. 2-Amino-5-ethyl-4-methylthiophene-3-carbonitrile (1a)
Yield 68% (Ethanol); m.p. 102-3 C; IR (KBr, cm1): 3332,
3185, 2968, 2912, 2215, 1622; 1H NMR (CDCl3, d): 1.39 (t,
3H, -CH3), 2.37 (s, 3H, -CH3), 2.99 (q, 2H, -CH2), 8.27 (s,
2H, -NH2, D2O exchangeable);
13C NMR (CDCl3, d): 9.68,
13.85, 20.73, 84.22, 116.4, 128.1, 135.07, 149.1; MS: m/z 124
(100%), 166 (M+); Anal. Calcd. (Found) for C8H10N2S: C,
57.80 (57.83); H, 6.06 (6.10); N, 16.85 (16.81).
2.2.2. 2-Amino-6-methyl-4,5,6,7-tetrahydrobenzo[b]thiophene-
3-carbonitrile (1f)
Yield 84% (Ethanol); m. p. 144-6 C; IR (KBr, cm1): 3334,
3190, 2969, 2900, 2219, 1621; 1H NMR (CDCl3, d): 1.24 (d,
3H, –CH3), 2.05 (m, 1H, ‚CH), 2.22 (d, 2H, -CH2), 2.46 (t,Please cite this article in press as: D.K. Sureja, K.R. Vadalia, POCl3 catalyzed, one-ste
tives as antimicrobial agentd]pyrimidin-4(3H)-one derivatives –>, Journal of Saudi2H, -CH2), 2.74 (t, 2H, -CH2), 8.29 (s, 2H, -NH2, D2O
exchangeable); 13C NMR (CDCl3, d): 20.33, 21.73, 28.3,
30.1, 31.55, 84.2, 116.4, 135.0, 138.1, 149.2; MS: m/z 150
(100%), 192 (M+); Anal. Calcd. (Found) for C10H12N2S: C,
62.46 (62.33); H, 6.29 (6.28); N, 14.57 (14.61).
2.2.3. 2-Amino-7-oxo-4,5,6,7-tetrahydrobenzo[b]thiophene-3-
carbonitrile (1g)
Yield 74% (Dioxane); m.p. 215-7 C; IR (KBr, cm1): 3345,
3198, 2968, 2909, 2214, 1665, 1622; 1H NMR (DMSO-d6, d):
2.25 (m, 2H, -CH2), 2.85 (t, 2H, -CH2), 3.01 (t, 2H, -CH2),
8.30 (s, 2H, -NH2, D2O exchangeable);
13C NMR (DMSO-
d6, d): 22.5, 22.7, 37.5, 84.25, 116.6, 139.5, 149.2, 163.7;
MS: m/z 150 (100%), 192 (M+); Anal. Calcd. (Found) for
C9H8N2OS: C, 56.23 (56.33); H, 4.19 (4.10); N, 14.57 (14.63).
2.3. General procedure for preparation of thieno[2,3-d]
pyrimidin-4(3H)-one derivatives (2a–o)
2.3.1. Conventional synthesis
2-Amino-4,5-substitutedthiophene-3-carbonitrile (1a–g)
(1 mM) was dissolved in appropriate aliphatic acid (2 mL).
Then POCl3 (0.2 mL) was added drop wise and the reaction
mixture has been kept for reflux on a boiling water bath.
The reaction progress was supervised using TLC. After com-
pletion of the reaction, the mixture was poured on ice-cold
water (50 mL) and crude precipitates thus formed were filtered,
washed with 10% sodium bicarbonate solution, dried and
recrystallized from a suitable solvent.
2.3.2. Microwave assisted synthesis
A mixture of 2-amino-4,5-substitutedthiophene-3-carbonitrile
(1a–g) (1 mM), appropriate aliphatic acid (2 mL) and alumina
(0.5 g) were finely crushed and transferred to a glass vial and
then phosphorus oxychloride (0.2 mL) was added to this mix-
ture. The glass vial was then capped and microwaves were irra-
diated in a microwave oven (CEM, Discover microwave lab
station, 2450 MHz with temperature control) at the power of
960 W for 2-4 min. After the completion of reaction (reaction
monitoring by TLC), the mixture was poured on ice-cold water
(50 mL). The precipitated product was filtered and washed
with 10% sodium bicarbonate solution to give the desired
compounds.
2.3.3. 6-Ethyl-5-methylthieno[2,3-d]pyrimidin-4(3H)-one (2a)
IR (KBr, cm1): 3164, 3071, 2969, 2910, 1667, 1578; 1H NMR
(DMSO-d6, d): 1.32 (t, 3H, –CH3), 2.38 (s, 3H, –CH3), 2.90 (q,
2H, –CH2), 8.10 (s, 1H, ‚CH), 11.90 (s, 1H, –NH of pyrim-
idine, D2O exchangeable);
13C NMR (DMSO-d6, d): 9.68,
13.85, 20.53, 118.4, 132.1, 134.07, 145.7, 156.2, 161.0; MS:
m/z 194 (100%, M+).
2.3.4. 6-Ethyl-2,5-dimethylthieno[2,3-d]pyrimidin-4(3H)-one
(2b)
IR (KBr, cm1): 3156, 3067, 2976, 2918, 1665, 1574; 1H NMR
(CDCl3, d): 1.32 (t, 3H, –CH3), 2.37 (s, 3H, –CH3), 2.49 (s, 3H,
–CH3), 2.91 (q, 2H, –CH2), 11.87 (s, 1H, –NH of pyrimidine,
D2O exchangeable);
13C NMR (CDCl3, d): 9.7, 13.9, 20.5,
21.4, 118.3, 131.9, 133.87, 153.7, 156.2, 161.0; MS: m/z 208
(100%, M+).p, solvent-free synthesis of some novel thieno[2,3-d]pyrimidin-4(3H)-one deriva-
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(2c)
IR (KBr, cm1): 3159, 3070, 2973, 2908, 1668, 1583; 1H NMR
(CDCl3, d): 1.29 (t, 3H, –CH3), 1.36 (t, 3H, –CH3), 2.39 (s, 3H,
–CH3), 2.74 (q, 2H, –CH2), 2.93 (q, 2H, –CH2), 11.90 (s, 1H, –
NH of pyrimidine, D2O exchangeable);
13C NMR (CDCl3, d):
9.8, 10.4, 13.9, 20.39, 26.4, 118.25, 131.5, 133.3, 154.9, 156.2,
161.1; MS: m/z 222 (100%, M+).
2.3.6. 6-Ethyl-2-methylthieno[2,3-d]pyrimidin-4(3H)-one (2d)
IR (KBr, cm1): 3168, 3070, 2968, 2909, 1664, 1580; 1H NMR
(CDCl3, d): 1.35 (t, 3H, –CH3), 2.45 (s, 3H, –CH3), 2.95 (q,
2H, –CH2), 7.01 (s, 1H,‚CH), 11.92 (s, 1H, –NHof pyrimidine,
D2O exchangeable);
13C NMR (CDCl3, d): 15.9, 21.4, 22.6,
124.45, 133.1, 139.4, 154.1, 156.3, 161.0; MS: m/z 194 (100%,
M+).
2.3.7. 2,6-Diethylthieno[2,3-d]pyrimidin-4(3H)-one (2e)
IR (KBr, cm1): 3164, 3073, 2970, 2905, 1661, 1587; 1H NMR
(CDCl3, d): 1.29 (t, 3H, –CH3), 1.36 (t, 3H, –CH3), 2.74 (q, 2H,
–CH2), 2.93 (q, 2H, –CH2), 7.02 (s, 1H,‚CH), 11.90 (s, 1H, –
NH of pyrimidine, D2O exchangeable);
13C NMR (CDCl3, d):
10.45, 16.0, 22.4, 26.6, 124.5, 133.1, 139.2, 154.1, 156.3, 161.0;
MS: m/z 208 (100%, M+).
2.3.8. 5-Ethyl-2,6-dimethylthieno[2,3-d]pyrimidin-4(3H)-one (2f)
IR (KBr, cm1): 3154, 3063, 2977, 2918, 1666, 1575; 1H NMR
(CDCl3, d): 1.29 (t, 3H, –CH3), 2.39 (s, 3H, –CH3), 2.47 (s, 3H,
–CH3), 2.87 (q, 2H, –CH2), 11.78 (s, 1H, –NH of pyrimidine,
D2O exchangeable);
13C NMR (CDCl3, d): 10.35, 15.4, 17.6,
21.45, 120.5, 127.0, 133.6, 154.2, 156.2, 161.0; MS: m/z 208
(100%, M+).
2.3.9. 2,5-Diethyl-6-methylthieno[2,3-d]pyrimidin-4(3H)-one
(2g)
IR (KBr, cm1): 3157, 3074, 2970, 2912, 1663, 1578; 1H NMR
(CDCl3, d): 1.29 (t, 3H, –CH3), 1.34 (t, 3H, –CH3), 2.36 (s, 3H,
–CH3), 2.74 (q, 2H, –CH2), 2.93 (q, 2H, –CH2), 11.90 (s, 1H, –
NH of pyrimidine, D2O exchangeable);
13C NMR (CDCl3, d):
10.32, 10.45, 15.42, 17.7, 26.45, 118.5, 127.0, 133.6, 154.2,
156.3, 161.0; MS: m/z 222 (100%, M+).
2.3.10. 2-Ethyl-6,7-dihydro-3H-cyclopenta[4,5]thieno[2,3-d]
pyrimidin-4(5H)-one (2h)
IR (KBr, cm1): 3221, 3074, 2970, 2856, 1674, 1578; 1H NMR
(CDCl3, d): 1.31 (t, 3H, -CH3), 2.47 (pentet, 2H, –CH2), 2.73
(q, 2H, –CH2), 2.94 (t, 2H, –CH2), 3.03 (q, 2H, –CH2), 11.97
(s, 1H, –NH of pyrimidine, D2O exchangeable);
13C NMR
(CDCl3, d): 10.42, 24.8, 25.5, 26.45, 32.0, 118.3, 125.6, 139.5,
154.2, 156.3, 161.0; MS: m/z 220 (100%, M+).
2.3.11. 2-Ethyl-6,7,8,9-tetrahydro-3H-cyclohepta[4,5]thieno
[2,3-d]pyrimidin-4(5H)-one (2i)
IR (KBr, cm1): 3210, 3064, 2975, 2857, 1679, 1568; 1H NMR
(CDCl3, d): 1.33 (t, 3H, –CH3), 1.69 (m, 4H, -CH2), 1.90 (pen-
tet, 2H, –CH2), 2.47 (pentet, 2H, –CH2), 2.82 (t, 2H, –CH2),
3.33 (t, 2H, –CH2), 11.85 (s, 1H, –NH of pyrimidine, D2O
exchangeable): 13C NMR (CDCl3, d): 10.4, 20.1, 26.2, 26.55,
27.8, 28.8, 29.3, 118.3, 125.6, 139.5, 154.2, 156.3, 161.1; MS:
m/z 248 (100%, M+).Please cite this article in press as: D.K. Sureja, K.R. Vadalia, POCl3 catalyzed, one-ste
tives as antimicrobial agentd]pyrimidin-4(3H)-one derivatives –>, Journal of Saudi2.3.12. 7-Methyl-5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-d]
pyrimidin-4(3H)-one (2j)
IR (KBr, cm1): 3178, 3076, 2972, 2856, 1665, 1576; 1H NMR
(CDCl3, d): 1.31 (d, 3H, –CH3), 2.06 (m, 1H, ‚CH), 2.18 (d,
2H, CH2), 2.43 (t, 2H, CH2), 2.74 (t, 2H, CH2), 7.84 (s,
1H,‚CH), 11.82 (s, 1H, NH of pyrimidine, D2O exchange-
able); 13C NMR (CDCl3, d): 20.4, 21.8, 28.7, 30.1, 31.6, 118.2,
125.5, 139.4, 145.7, 155.2, 161.0; MS: m/z 220 (100%, M+).
2.3.13. 2,7-Dimethyl-5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-d]
pyrimidin-4(3H)-one (2k)
IR (KBr, cm1): 3175, 3074, 2972, 2856, 1666, 1577; 1H NMR
(CDCl3, d): 1.30 (d, 3H, –CH3), 2.06 (m, 1H, ‚CH), 2.18 (d,
2H, –CH2), 2.37 (s, 3H, –CH3), 2.43 (t, 2H, –CH2), 2.74 (t, 2H,
–CH2), 11.81 (s, 1H, –NH of pyrimidine, D2O exchangeable);
13C NMR (CDCl3, d): 20.4, 21.3, 21.8, 28.7, 30.1, 31.6, 118.2,
125.5, 139.4, 154.2, 155.25, 161.0; MS: m/z 234 (100%, M+).
2.3.14. 2-Ethyl-7-methyl-5,6,7,8-tetrahydrobenzo[4,5]thieno
[2,3-d]pyrimidin-4(3H)-one (2l)
IR (KBr, cm1): 3176, 3076, 2978, 2850, 1665, 1572; 1H NMR
(CDCl3, d): 1.26 (t, 3H, –CH3), 1.31 (d, 3H, –CH3), 2.05 (m,
1H, ‚CH), 2.18 (d, 2H, –CH2), 2.43 (t, 2H, –CH2), 2.74 (t,
2H, –CH2), 2.87 (q, 2H, –CH2), 11.80 (s, 1H, –NH of pyrim-
idine, D2O exchangeable);
13C NMR (CDCl3, d): 10.5, 20.45,
21.8, 26.4, 28.7, 30.15, 31.6, 118.2, 125.45, 139.42, 155.2,
156.4, 161.0; MS: m/z 248 (100%, M+).
2.3.15. 6,7-Dihydrobenzo[4,5]thieno[2,3-d]pyrimidin-4,8
(3H,5H)-dione (2m)
IR (KBr, cm1): 3225, 3086, 2965, 2857, 1672, 1565; 1H NMR
(CDCl3, d): 2.43 (t, 2H, –CH2), 2.74 (pentet, 2H, –CH2), 2.92
(t, 2H, –CH2), 7.53 (s, 1H,‚CH), 12.03 (s, 1H, –NH of pyrim-
idine, D2O exchangeable);
13C NMR (CDCl3, d): 22.6, 22.8,
38.1, 119.8, 139.4, 145.65, 161.1, 162.2, 166.9, 191.2; MS: m/
z 220 (100%, M+).
2.3.16. 2-Methyl-6,7-dihydrobenzo[4,5]thieno[2,3-d]
pyrimidine-4,8(3H,5H)-dione (2n)
IR (KBr, cm1): 3215, 3096, 2961, 2854, 1671, 1565; 1HNMR
(CDCl3, d): 2.37 (s, 3H, –CH3), 2.43 (t, 2H, –CH2), 2.73 (pen-
tet, 2H, –CH2), 2.92 (t, 2H, –CH2), 12.05 (s, 1H, –NH of
pyrimidine, D2O exchangeable);
13C NMR (CDCl3, d): 21.3,
22.6, 22.8, 38.1, 119.8, 139.4, 154.4, 161.1, 162.2, 166.9,
191.2; MS: m/z 234 (100%, M+).
2.3.17. 2-Ethyl-6,7-dihydrobenzo[4,5]thieno[2,3-d]pyrimidine-
4,8(3H,5H)-dione (2o)
IR (KBr, cm1): 3221, 3090, 2967, 2855, 1670, 1563; 1H NMR
(CDCl3, d): 1.29 (t, 3H, –CH3), 2.42 (t, 2H, –CH2), 2.73 (pen-
tet, 2H, –CH2), 2.87 (q, 2H, –CH2), 2.93 (t, 2H, –CH2), 12.07
(s, 1H, –NH of pyrimidine, D2O exchangeable);
13C NMR
(CDCl3, d): 10.4, 22.6, 22.8, 26.5, 38.1, 119.8, 139.4, 155.4,
161.0, 162.2, 166.9, 191.3; MS: m/z 248 (100%, M+).
2.4. Biological screening
2.4.1. Antibacterial activity
Both Gram (+)ve (Staphylococcus aureus and Bacillus subtilis)
and Gram (-)ve (Pseudomonas aerusinosa and Escherichia coli)p, solvent-free synthesis of some novel thieno[2,3-d]pyrimidin-4(3H)-one deriva-
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2c: R= -C2H5, R1= -CH3, R2= -C2H5
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2e: R= -C2H5, R1= -H, R2= -C2H5
2f: R= -CH3, R1= -C2H5, R2= -CH3
2g: R= -C2H5, R1= -C2H5, R2= -CH3
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2j: R= -H, R1,R2= -CH2CH2CH(CH3)CH2-
2k: R= -CH3, R1,R2= -CH2CH2CH(CH3)CH2-
2l: R= -C2H5, R1,R2= -CH2CH2CH(CH3)CH2-
2m: R= -H, R1,R2= -(CH2)3CO-
2n: R= -CH3, R1,R2= -(CH2)3CO-
2o: R= -C2H5, R1,R2= -(CH2)3CO-
ii or iii
Reaction conditions: i = Ethanol, DEA, stirring, 45-50°C
ii = POCl3, ref lux, 1.5-2.5 h, (70-83%)
iii = Al2O3, POCl3, MW irradiation, 2-4 min, (78-90%)
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O
Scheme 1 Synthetic route of compounds 2a–o.
Table 1 Physicochemical and analytical data of thieno[2,3-d]pyrimidin-4(3H)-one derivatives (2a–o).
Compd. M.P. (C) Recrystalisation solvent Molecular formula (M.W.) Elemental analysis
Calculated % Found %
C H N C H N
2a 203-4 Methanol C9H10N2OS (194.25) 55.65 5.19 14.42 55.53 5.20 14.53
2b 208-9 Ethanol C10H12N2OS (208.28) 57.67 5.81 13.45 57.63 5.75 13.48
2c 200-1 Ethanol C11H14N2OS (222.31) 59.43 6.35 12.60 59.56 6.40 12.49
2d 206-7 Ethanol C9H10N2OS (194.25) 55.65 5.19 14.42 55.53 5.20 14.53
2e 192-4 Ethanol C10H12N2OS (208.28) 57.67 5.81 13.45 57.60 5.80 13.48
2f 211-2 Ethanol C10H12N2OS (208.28) 57.67 5.81 13.45 57.61 5.75 13.43
2g 202-3 Ethanol C11H14N2OS (222.31) 59.43 6.35 12.60 59.56 6.40 12.49
2h 198-9 Ethyl acetate C11H12N2OS (220.29) 59.97 5.49 12.72 59.90 5.44 12.68
2i 210-1 Ethyl acetate C13H16N2OS (248.34) 62.87 6.49 11.28 62.90 6.44 11.23
2j 154-6 Ethanol C11H12N2OS (220.29) 59.97 5.49 12.72 59.89 5.69 12.43
2k 208-9 Ethanol C12H14N2OS (234.32) 61.51 6.02 11.96 61.38 5.96 12.04
2l 160-2 Ethyl acetate C13H16N2OS (248.34) 62.87 6.49 11.28 62.79 6.41 11.31
2m 254-6 Ethanol C10H8N2O2S (220.25) 54.53 3.66 12.72 54.41 3.59 12.80
2n 286-7 Ethanol C11H10N2O2S (234.27) 56.39 4.30 11.96 56.41 4.41 11.86
2o 260-2 Ethanol C12H12N2O2S (248.30) 58.05 4.87 11.28 58.10 4.90 11.18
4 D.K. Sureja, K.R. Vadaliabacteria were used for in vitro antibacterial study by the agar
well diffusion method [16]. Various solutions (50 lg/mL) of
all test compounds and streptomycin were prepared in DMSO.
Mueller-Hinton agar media was sterilized for 15 min. at 121 C
and transferred to sterile petri plates to form a uniform layer
and then allowed to solidify. The different strains of bacteria
were then inoculated uniformly on solidified agar media using
a sterile cotton swab. The bores were made in agar plates using
a 6 mm sterile borer and filled with 0.1 mL of all test solutions
and streptomycin solution. The plates were then incubated at
37 C for a period of 24 h and the zone of inhibition (mm)
was measured. DMSO solution was used as control.
2.4.2. Antifungal activity
In vitro antifungal activity of all the compounds was screened
against Candida albicans and Aspergillus niger by agar well dif-
fusion method [17]. Various solutions (50 lg/mL) of all test
compounds and amphotericin B were prepared in DMSO.
Sterilized molten mass of potato dextrose agar was poured into
previously sterilized petri plates and kept at room temperature
to solidify. The fungi were then inoculated on the solidified
media using a sterile cotton swab. The bores were made in agar
plates with the help of a 6 mm sterile borer and 0.1 mL of allPlease cite this article in press as: D.K. Sureja, K.R. Vadalia, POCl3 catalyzed, one-ste
tives as antimicrobial agentd]pyrimidin-4(3H)-one derivatives –>, Journal of Sauditest solutions, DMSO and amphotericin B solution was added.
All the plates were then incubated at 37 C for a period of 24-
48 h and the zone of inhibition was measured in mm.
3. Results and discussion
The starting material 2-amino-4,5-substitutedthiophene-3-car
bonitrile (1a–g) was attained in good yield by condensation
reaction of appropriate ketone/aldehyde, elemental sulfur
and malanonitrile as reported earlier [18]. Although, solvent
free microwave assisted synthetic method has been recently
reported [19,20], Gewald’s conventional method is more prac-
tical and economical as far as the synthesis of 2-
aminothiophene is concerned. Therefore, compounds (1a–g)
were prepared in sufficient quantities by Gewald reaction.
The formation of compounds was confirmed from analysis
of their spectral and elemental data. The IR spectrum of com-
pound 1a showed symmetric and asymmetric stretching of the
primary amino group (3185 and 3332 cm1) and the presence
of a cyano group (2215 cm1). The 1H NMR of 1a showed a
triplet and quartet at d 1.39 (3H) and 2.99 (2H) respectively,
indicating the presence of an ethyl at 5th position of the thio-
phene ring and a singlet at d 2.37 indicating the presence ofp, solvent-free synthesis of some novel thieno[2,3-d]pyrimidin-4(3H)-one deriva-
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Table 2 Comparison of conventional and microwave assisted
synthesis.
Compd. Conventional method Microwave assisted method
Reaction time
(h)
%
Yield*
Reaction time
(min)
%
Yield*
2a 1.5 82 2 90
2b 2 79 2.5 86
2c 2.5 81 3 88
2d 2 83 2.5 89
2e 2.5 79 3.5 85
2f 2 78 2.5 84
2g 2.5 75 3.5 81
2h 2.5 71 3.5 79
2i 2.5 70 4 78
2j 2 76 2 82
2k 2 77 2.5 84
2l 2.5 75 3 81
2m 2 78 2.5 83
2n 2 73 2.5 82
2o 2.5 72 3.5 85
* Yield refers to pure isolated products.
POCl3 catalysed synthesis of thieno[2,3-d]pyrimidin-4(3H)-one derivatives 5a methyl at 4th position of the thiophene ring. The two protons
of the NH2 at 2
nd position of thiophene ring appeared at 8.27
which is D2O exchangeable, whereas its
13C NMR spectra
showed the characteristic peaks at d 9.68 (CH3 at C-4), 13.85
and 20.73 (CH3 and CH2 at C-5), 84.22 (C-3), 116.4 (C‚N),
128.1 (C-4), 135.07 (C-5), 149.1 (C-2) ppm respectively. In
mass spectrum, the molecular ion peak (M+) appeared at
m/z 166, which was identical with its molecular formula.
A number of syntheses of thieno[2,3-d] pyrimidin-4(3H)-
one have been reported in the literature [21–23]. However,
these methods suffer from some disadvantages like the use of
hydrogen chloride gas, low yield (20–40%) etc. Literature sur-Table 3 Antimicrobial activity of newly synthesized thieno[2,3-d]py
*Zone of inhibition (in mm) ± S.D.
Compound Gram (+)ve bacteria Gram (
B. subtilis S. aureus E. coli
2a 7.33 ± 0.58 7.67 ± 1.15 10.00 ±
2b 7.67 ± 0.58 8.33 ± 0.58 10.67 ±
2c 7.33 ± 0.58 7.67 ± 0.58 9.33 ±
2d 8.33 ± 0.58 8.67 ± 0.58 10.00 ±
2e 7.67 ± 1.15 7.67 ± 0.58 9.67 ±
2f 8.33 ± 0.58 8.67 ± 1.15 10.67 ±
2g 8.00 ± 1.00 9.67 ± 0.58 10.67 ±
2h 7.67 ± 0.58 8.00 ± 1.00 11.33 ±
2i 8.67 ± 0.58 9.00 ± 1.00 11.67 ±
2j 10.33 ± 0.58 9.33 ± 0.58 12.00 ±
2k 10.67 ± 0.58 9.67 ± 1.15 13.33 ±
2l 10.33 ± 0.58 10.00 ± 1.00 11.00 ±
2m 11.67 ± 0.58 9.67 ± 1.15 12.00 ±
2n 11.67 ± 1.15 9.67 ± 0.58 11.67 ±
2o 11.33 ± 0.58 9.00 ± 1.00 10.67 ±
Streptomycin 17.00 ± 1.00 19.67 ± 1.53 20.67 ±
Amphotericin B – – –
Control – – –
* Average of triplicate reading at conc. 50 lg/mL; S.D. = Standard De
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ester of thiophene to thienopyrimidines via thienooxazinones
which truncated the usage of HCl gas. However, in this route
the yield was reduced upto 40–50% [24]. This gave us an impe-
tus to develop a new route to synthesize the target molecule
that may restrict the use of HCl gas, without affecting % yield.
Nanda and Trotter [25] reported the use of POCl3 in the
synthesis of 2-trifluoroethylbenzimidazoles by intramolecular
cyclization reaction. Therefore compounds (1a–g) were reacted
with aliphatic acids in the presence of POCl3 to give thieno[2,3-
d]pyrimidin-4(3H)-one derivatives. A microwave assisted, sol-
vent free method is also developed which gives better yield
and requires a shorter reaction time compared to conventional
synthesis. These reactions are summarized in Scheme 1. The
physicochemical and micro-analytical data of synthesized
compounds are presented in Table 1. Both synthetic methods
are compared in terms of % yield and reaction time. The
results are presented in Table 2.
The spectral and micro analytical data confirmed the struc-
tures of newly synthesized compounds. For example, IR spec-
trum of 2a showed a peak at 3164 cm1 for the secondary
amino group, disappearance of cyano group at 2215 cm1
and appearance of a carbonyl group at 1667 cm1 indicated
cyclization of 3-cyano-2-aminothiophene. The 1H NMR spec-
trum in CDCl3 showed a triplet of methyl and quartet of
methylene proton of ethyl at d 1.32 and 2.90 ppm respectively
as well as a singlet of methyl at d 2.38 ppm. Spectrum also
showed a singlet broad peak at d 11.90 ppm of D2O exchange-
able secondary amino group of pyrimidine. The characteristic
signal for the aromatic proton was observed at d 8.10 ppm.
Similarly, its 13C NMR spectrum showed the characteristic
peaks at d 9.68 (CH3 at C-5), 13.85 and 20.53 (CH3 and
CH2 at C-6), 118.4 (C-4a), 132.1 (C-5), 134.07 (C-6), 145.7
(C-2), 156.2 (C-1a), 161.0 (C‚O) ppm respectively, which con-
firmed replacement of the cyano group by a carbonyl group i.e.
formation of thieno[2,3-d]pyrimidin-4(3H)-one. The molecularrimidin-4(3H)-one derivatives (2a-o).
-)ve bacteria Fungi
P. aeruginosa C. albicans A. niger
1.00 8.67 ± 1.15 9.00 ± 1.00 9.33 ± 0.58
0.58 9.33 ± 0.58 9.33 ± 0.58 8.67 ± 1.15
0.58 9.00 ± 1.00 8.67 ± 1.15 8.33 ± 0.58
1.00 9.67 ± 0.58 9.33 ± 0.58 9.00 ± 1.00
0.58 10.00 ± 1.00 9.00 ± 1.00 9.33 ± 0.58
1.15 10.33 ± 0.58 9.67 ± 0.58 9.67 ± 0.58
0.58 10.00 ± 1.00 9.33 ± 1.15 9.33 ± 0.58
0.58 10.67 ± 0.58 10.00 ± 1.00 10.00 ± 1.00
0.58 10.33 ± 0.58 9.67 ± 0.58 9.67 ± 1.15
1.00 10.67 ± 1.15 11.67 ± 0.58 10.67 ± 0.58
0.58 11.00 ± 1.00 11.33 ± 1.53 10.67 ± 0.58
1.00 10.67 ± 1.15 11.33 ± 1.15 10.00 ± 1.00
1.00 10.67 ± 0.58 10.67 ± 0.58 10.33 ± 1.15
1.15 10.33 ± 0.58 10.33 ± 0.58 9.67 ± 0.58
0.58 11.00 ± 1.00 10.00 ± 1.00 9.33 ± 1.15
0.58 19.33 ± 0.58 – –
– 16.33 ± 0.58 17.33 ± 0.58
– – –
viation.
p, solvent-free synthesis of some novel thieno[2,3-d]pyrimidin-4(3H)-one deriva-
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6 D.K. Sureja, K.R. Vadaliaion peak of compound 2a was observed at m/z 194 (M+),
which is in full agreement with its molecular formula.
All the newly synthesized compounds were screened in vitro
for their preliminary antimicrobial activity against various
microorganisms. The results of preliminary in vitro antimicro-
bial testing of compounds 2a–o are shown in Table 3.
The result showed that the entire series of synthesized com-
pounds exhibit weak to good activities as compared to stan-
dard drugs against all tested microorganisms. From
antimicrobial data it can be concluded that methyl cyclohex-
ane and cyclohexanone group on the thiophene ring, exhibited
better activity against all tested microorganisms compared to
other alkyl and cycloalkyl substituted thieno[2,3-d]pyrimidin-
4(3H)-one. The compounds bearing methylcyclohexyl group
(2j, 2k and 2l) has shown the highest sensitivity against S. aur-
eus, E. coli, P. aerusinosa, A. niger and C. albicans. Cyclohex-
anone substituent containing compounds (2m, 2n and 2o) were
found to possess good activity against B. subtilis and P. aerug-
inosa. Furthermore, it is also concluded that –H, –CH3 and –
C2H5 substitutions at 6
th position have less effect and slightly
modify the antimicrobial activity over a wide range of tested
microorganisms.4. Conclusion
To conclude, we have successfully developed POCl3 catalyzed,
efficient, one-step, solvent-free synthesis of thieno[2,3-d]
pyrimidin-4(3H)-one derivatives by conventional and micro-
wave irradiation techniques. All the tested compounds showed
weak to moderate antimicrobial activity against all bacteria
and fungi used, it indicates that thieno[2,3-d]pyrimidin-4
(3H)-one can be a potential lead for the development of
antimicrobial agents.Acknowledgements
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